PMCF Solutions & Clinical Data Services

PMCF stands for Post-Market Clinical Follow-Up. In clinical research for medical devices, it refers to ongoing activities performed after market approval to collect and evaluate clinical data on safety, performance, and benefit-risk in real-world use. PMCF can include surveys, registries, literature reviews, observational studies, and other structured methods that support continued compliance and clinical evaluation updates.

PMCF means Post-Market Clinical Follow-Up. It is a regulatory and clinical process used to gather additional data on a medical device after it is already on the market. The goal is to confirm continued safety and performance, identify emerging risks, and support documents such as PMCF evaluation reports, Clinical Evaluation Reports, and broader post-market surveillance records.

PMCF is required for most medical devices under EU MDR unless a manufacturer can clearly justify that it is not necessary based on the device's characteristics, risk profile, and existing clinical evidence. Regulators and Notified Bodies expect a documented rationale, a proportionate PMCF plan, and evidence that post-market clinical data is being actively reviewed as part of the clinical evaluation lifecycle.

A PMCF plan can include literature reviews, user surveys, registry analysis, complaint trend reviews, post-market clinical studies, follow-up questionnaires, and analysis of real-world clinical data. The selected methods should match the device's risk, novelty, intended use, and evidence gaps. A strong PMCF plan explains why each method was chosen and how the resulting data will be evaluated and reported.

PMCF is closely linked to both the Clinical Evaluation Report and Post-Market Surveillance system. PMCF generates clinical data that can confirm safety and performance claims, address residual risks, and support benefit-risk conclusions in the CER. At the same time, PMCF should align with PMS outputs such as complaints, trend analysis, and field feedback so post-market evidence is reviewed as one connected system.

A regulator-ready PMCF evaluation report is clear, traceable, and methodologically sound. It should summarize the PMCF activities performed, explain the data sources used, analyze findings objectively, and connect conclusions back to safety, performance, and benefit-risk. Reviewers also expect consistency with the PMCF plan, CER, risk management file, and PMS documentation, with no unexplained gaps or unsupported claims.

Yes. Elexes supports PMCF adequacy reviews, gap assessments, remediation planning, and documentation development. That can include reviewing existing PMCF plans and reports, identifying weaknesses in study design or rationale, improving traceability to CER and PMS records, and helping your team build a more defensible post-market clinical evidence package that is aligned with current regulatory expectations.

PMCF is most commonly associated with EU MDR, but the underlying need for post-market clinical evidence can affect broader regulatory strategy as well. Clinical data gathered through PMCF may support global submissions, change assessments, risk management updates, and ongoing post-market governance. Elexes helps manufacturers structure these activities so the evidence remains useful across multiple regulatory and quality contexts.